Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal failure and esterase-negative monocytes

D R Hull1, G M Markey, T C Morris

  • 1Haematology Laboratory, Belfast City Hospital Trust, Northern Ireland.

Renal Failure
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review of the NICE guidelines for multiple myeloma.

International journal of laboratory hematology·2016
Same author

An Analysis of Circulating CD4 Lymphocyte Subpopulations in B-Cell Chronic Lymphocytic Leukaemia.

Leukemia & lymphoma·2016
Same author

Blister-like aneurysm of the anterior communicating artery.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2009
Same author

Clarithromycin with low dose dexamethasone and thalidomide is effective therapy in relapsed/refractory myeloma.

British journal of haematology·2008
Same author

Idiopathic pure red cell aplasia: first report on CD8 positive lymphocytosis in bone marrow biopsy sections.

Journal of clinical pathology·2005
Same author

WHO reclassification of breast lymphomas.

Journal of clinical pathology·2004
Same journal

Pentoxifylline and cardiorenal outcomes in advanced CKD with untreated dyslipidemia: a longitudinal cohort study.

Renal failure·2026
Same journal

Risk factors and temporal trends of early urological complications after kidney transplantation: a 15-year single-center cohort study.

Renal failure·2026
Same journal

SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism.

Renal failure·2026
Same journal

Hypoxia-inducible factor-1α promotes epithelial-to-mesenchymal transition through upregulating cathepsin S expression in diabetic kidney disease.

Renal failure·2026
Same journal

Development and validation of a dual-channel deep learning for continuous acute kidney injury prediction in critically ill patients.

Renal failure·2026
Same journal

Relaxin inhibits renal interstitial fibrosis and promotes fatty acid metabolism after UUO <i>via</i> the AMPK/PGC1α signaling pathway.

Renal failure·2026
See all related articles

Monocyte esterase deficiency (MED) is more common in kidney disease patients. Rising serum phosphate levels are linked to increased esterase-negative monocytes (ENMs), potentially explaining immune issues in chronic kidney failure.

Area of Science:

  • Immunology
  • Nephrology
  • Hematology

Background:

  • Monocyte esterase deficiency (MED) is associated with autoimmune and lymphoproliferative diseases.
  • MED, defined by >85% of monocytes lacking esterase activity, is more prevalent in renal failure patients (3.8%) than healthy donors (0.8%).
  • The occurrence of any proportion of esterase-negative monocytes (ENMs) in renal disease patients was previously unstudied.

Purpose of the Study:

  • To document the occurrence of ENMs in renal disease patients.
  • To identify clinical and biochemical factors associated with ENMs.
  • To explore potential reasons for ENM occurrence in renal failure.

Main Methods:

  • Re-examination of original survey data from Belfast City Hospital (1987).
  • Extraction of previously unreported ENM occurrence data from renal patient records.

Related Experiment Videos

  • Analysis of clinical and biochemical parameters from patient hospital notes to find associations with ENMs.

    • Main Results:

    • ENMs occurred in a significantly higher proportion (31%) of renal patients compared to normal (8%) or other hospital populations (p < 0.001).
    • A significant association was found between increasing serum phosphate levels and higher proportions of ENMs (p < .001).
    • This association was independent of serum creatinine levels and renal dialysis status.

    Conclusions:

    • Esterase-negative monocytes are significantly increased in renal failure patients.
    • Rising serum phosphate levels are strongly associated with increased ENMs, independent of renal function severity or treatment.
    • This finding may contribute to understanding immunological complications in chronic kidney disease.